Searching for novel multimodal treatments in oligometastatic pancreatic cancer

Searching for novel multimodal treatments in oligometastatic pancreatic cancer

Abstract Background Metastatic pancreatic cancer has a median overall survival of less than 12 months, even if treated with chemotherapy. Selected patients with oligometastatic disease could benefit from multimodal treatments connecting chemotherapy and surgical treatment or radiofrequency ablation...

Full description

Bibliographic Details
Main Authors: D. M. Filippini, E. Grassi, A. Palloni, R. Carloni, R. Casadei, C. Ricci, C. Serra, G. Ercolani, G. Brandi, M. Di Marco
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
Oligometastatic cancer
Metastasectomy
Multimodal treatment
Online Access:http://link.springer.com/article/10.1186/s12885-020-06718-3

Internet

http://link.springer.com/article/10.1186/s12885-020-06718-3

Similar Items